Latest news

Bio-Gene Technology ASX BGT Flavocide grain storage pest BASF Queensland DAF GRDC

Bio-Gene achieves key milestone during development of its Flavocide pesticide

Agriculture technology (AgTech) company Bio-Gene Technology (ASX: BGT) has reported results from a recent grain storage program and said its Flavocide product was able to meet key industry standards. Results confirmed that Flavocide continued to demonstrate...
Lithium Australia ASX LIT battery recycler Envirostream 90%

Lithium Australia boosts stake in battery recycler Envirostream to 90%

In yet another move to boost its presence in Australia’s battery recycling space, Lithium Australia (ASX: LIT)  has agreed to increase its interest in leading battery recycler Envirostream Australia Pty Ltd from 74% to...
Wattle Health Australia ASX WHA Chemist Warehouse Uganic Little Innoscents Ranges

Wattle Health looks to boost distribution via supply agreement with Chemist Warehouse

Nutritional products maker Wattle Health Australia (ASX: WHA) has struck a deal that will see its organic nutritional dairy range stocked in as many as 450 Chemist Warehouse stores across Australia. Wattle Health unveiled a 10-year supply...
Back to the future economic growth low interest rates

Back to the future with sluggish economic growth and low interest rates

They say those who fail to learn the lessons of history are doomed to repeat it. And some interesting economic analysis is pointing to that happening at the moment as real global growth remains negative...
Amaero International ASX IPO 3d printing additive manufacturing

Amaero International lists on ASX after heavily oversubscribed IPO

Monash University spin-off Amaero International (ASX: 3DA) has raised $8 million through a heavily oversubscribed initial public offering to list on the Australian Stock Exchange today in a bid to expand its operations. The offering...
Impression Healthcare ASX IHL files patent non-intrusive treatment obstructive sleep apnoea pill

Impression Healthcare files patent for non-intrusive treatment of obstructive sleep apnoea

Medical cannabis company Impression Healthcare (ASX: IHL) is continuing on its path to developing an effective solution for obstructive sleep apnoea (OSA) having filed a patent application covering IHL-42X in pill form. Impression intends to radically...
Macarthur Minerals IPO ASX MIO

Macarthur Minerals gives Australian investors access to advanced iron ore project with ASX debut

Iron ore explorer Macarthur Minerals is about to debut on the ASX, but unlike most juniors, which have a long road ahead, Macarthur has already begun work for a bankable feasibility study, secured major...
iSignthis Australian Federal Court proceedings ASX trading suspension

iSignthis launches Australian Federal Court proceedings against the ASX for prolonged trading suspension

iSignthis (ASX: ISX) has launched Australian Federal Court proceedings against the ASX regarding the “procedural fairness” of exchange’s decision to suspend its shares from trading for the past nine weeks. The company pointed to the...
OpenLearning IPO ASX OLL SaaS short courses education

OpenLearning to make ASX debut, refines SaaS business model

The team behind cloud-based platform OpenLearning plans to raise up to $8 million through an initial public offering this month to expand the company’s presence in Australasia and grow the portfolio of short courses...
Cynata Therapeutics ASX CYP sepsis blood poisoning Cymerus mesenchymal stem cells regenerative medicine MSC

Cynata Therapeutics has positive pre-clinical results using Cymerus stem cell platform to treat sepsis

Pre-clinical studies using Cynata Therapeutics’ (ASX: CYP) Cymerus mesenchymal stem cells in a sepsis model have achieved positive results. In a pre-clinical model of severe pneumonia-induced sepsis, Cynata’s Cymerus treatment had several positive effects including...